SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TAGLIATI, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.443
AS - Asia 3.639
EU - Europa 2.332
SA - Sud America 592
AF - Africa 76
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.090
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.294
SG - Singapore 1.468
CN - Cina 1.195
DE - Germania 590
BR - Brasile 494
UA - Ucraina 427
IT - Italia 334
HK - Hong Kong 314
GB - Regno Unito 256
TR - Turchia 250
VN - Vietnam 214
FI - Finlandia 212
SE - Svezia 129
RU - Federazione Russa 125
PL - Polonia 78
MX - Messico 66
CA - Canada 63
FR - Francia 55
AR - Argentina 47
IN - India 38
ID - Indonesia 36
ZA - Sudafrica 35
BE - Belgio 29
BD - Bangladesh 25
NL - Olanda 21
IQ - Iraq 20
JP - Giappone 19
ES - Italia 18
AT - Austria 17
LT - Lituania 15
EC - Ecuador 14
PK - Pakistan 13
EG - Egitto 10
KE - Kenya 8
UZ - Uzbekistan 8
CL - Cile 7
DZ - Algeria 7
VE - Venezuela 7
IR - Iran 6
MA - Marocco 6
PY - Paraguay 6
UY - Uruguay 6
CO - Colombia 5
JO - Giordania 5
AL - Albania 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
IE - Irlanda 4
NP - Nepal 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AU - Australia 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
EU - Europa 3
JM - Giamaica 3
LB - Libano 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
CH - Svizzera 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
ML - Mali 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
UG - Uganda 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PW - Palau 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
Totale 15.090
Salva come PNG Salva come JPEG
Città #
Ashburn 1.127
Singapore 904
Woodbridge 890
Fairfield 716
Chandler 565
Houston 521
Jacksonville 490
Beijing 414
Santa Clara 388
Ann Arbor 380
Hong Kong 311
Seattle 297
Wilmington 266
Cambridge 215
Addison 150
Munich 145
Los Angeles 143
Nanjing 137
Izmir 134
Ferrara 120
Dallas 115
New York 113
Princeton 99
Boardman 84
Warsaw 76
Ho Chi Minh City 75
Shanghai 75
Milan 72
Dearborn 67
Helsinki 61
San Diego 59
São Paulo 54
Turku 54
Hanoi 46
Mexico City 46
Shenyang 44
Bremen 40
Tianjin 38
Nanchang 36
Buffalo 33
Brooklyn 31
Changsha 31
Chicago 29
Hebei 29
Denver 28
Brussels 27
Hefei 25
Jinan 25
Johannesburg 25
Washington 25
Jakarta 24
London 24
Montreal 24
Mountain View 24
Atlanta 23
Frankfurt am Main 23
Nuremberg 22
Jiaxing 21
Orem 21
Kunming 20
Tappahannock 19
Tokyo 19
Toronto 18
Chennai 17
Boston 16
Phoenix 16
San Francisco 16
Falls Church 15
Guangzhou 15
Moscow 15
Ankara 14
Manchester 14
Brasília 13
Falkenstein 13
Norwalk 13
Poplar 13
Belo Horizonte 12
Redwood City 12
Stockholm 12
Auburn Hills 11
Baghdad 11
Biên Hòa 11
Da Nang 11
Leawood 11
Rome 11
Indiana 10
Ningbo 10
Padova 10
Rio de Janeiro 10
Verona 10
Bologna 9
Amsterdam 8
Charlotte 8
Lanzhou 8
Nairobi 8
San Mateo 8
Secaucus 8
Dong Ket 7
Haiphong 7
Orange 7
Totale 10.577
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 395
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 238
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 231
Igf-I influences everolimus activity in medullary thyroid carcinoma 224
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 222
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 217
Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function 213
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 213
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 211
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 211
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 207
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 200
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 197
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 197
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 195
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 192
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 190
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 189
Functional characterization of a new deletion in CDKN1B 5'-UTR region 186
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 185
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 182
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 181
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 179
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 178
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 177
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 175
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 174
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 173
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 172
Growth hormone excess promotes breast cancer chemoresistance 172
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 170
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 170
Growth hormone induces chemoresistance in breast cancer cells 169
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 166
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 166
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 165
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 164
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 164
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 163
miR-15a and miR-16-1 down-regulation in pituitary adenomas 161
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 161
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 159
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 157
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 157
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 153
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 153
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 150
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 150
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 150
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 148
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 144
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 143
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 143
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib 143
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 142
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 142
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 141
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 141
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 136
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 134
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 134
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 132
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 132
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 132
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 129
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 128
Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells 128
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 126
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 125
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 125
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 124
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 123
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 119
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 118
Effects of pasireotide on bronchial carcinoids in primary culture 117
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 117
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 117
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 116
Real-time PCR is useful to detect menin gene deletions 116
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 116
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 111
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 110
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 109
Targeting PKC in human pancreatic neuroendocrine tumor cells 108
null 106
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 106
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 102
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 102
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 101
A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia 97
Validation of a murine model to study deregulated pituitary microRNA 95
miR-26a targets PRKCD in ACTH pituitary adenoma 95
null 92
Characterization of Stable Pyrazole Derivatives of Curcumin with Improved Cytotoxicity on Osteosarcoma Cell Lines 87
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 86
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  82
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 77
α-Pinene, a Main Component of Pinus Essential Oils, Enhances the Expression of Insulin-Sensitive Glucose Transporter Type 4 in Murine Skeletal Muscle Cells 73
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 67
Role of piuitary tumour transforming gene 1 in medullary thyroid carcinoma 62
Totale 15.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021736 0 0 0 0 0 122 48 148 30 149 174 65
2021/20221.041 37 101 68 20 47 54 48 41 36 87 113 389
2022/20231.192 110 102 63 162 191 170 74 94 134 9 49 34
2023/2024908 60 66 28 19 59 105 23 373 19 13 8 135
2024/20252.397 52 46 192 66 312 328 67 70 343 243 365 313
2025/20263.745 716 302 557 785 1.199 186 0 0 0 0 0 0
Totale 15.205